Amgen's game-changing lung cancer treatment gains FDA approval | Pacific Coast Business Times
Amgen headquarters in Thousand Oaks. (file photo) Thousand Oaks-based Amgen has received approval from the U.S. Food and Drug Administration for its treatment, Imdelltra, which is used on adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. Announced May 16, Amgen said in a press release that Imdelltra